<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02681029</url>
  </required_header>
  <id_info>
    <org_study_id>Royan-Emb-023</org_study_id>
    <nct_id>NCT02681029</nct_id>
  </id_info>
  <brief_title>The Clinical Outcomes Following Transfer of Blastocysts Cultured From Thawed Cleavage Stage Embryos</brief_title>
  <official_title>Evaluating the Clinical Outcomes Following Transfer of Blastocysts Cultured From Thawed Cleavage Stage Embryos at Royan Institute: A Phase 3, Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Royan Institute</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Royan Institute</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Recent improvements in cell culture systems have led to a shift in in vitro fertilization
      (IVF) practice from early cleavage stage embryo transfer (ET) to blastocyst transfer.
      Blastocyst culture and transfer could theoretically provide better synchronization between
      the embryo and the uterine endometrium. The purpose of this study is comparing pregnancy
      rates and implantation rate following transfer of thawed cleavage embryos and blastocysts
      cultured from thawed cleavage embryos.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The proposal of this study approved by our institutional review boards and institution's
      ethical committee, and all participants will sign a written consent before enter to study.
      All patients will be randomly divided into two groups of thawed cleavage embryo transfers and
      transfers of blastocysts from thawed cleavage embryos. Embryos will be transferred in hormone
      replacement cycles. Preparation of the endometrium will be started in the second day of
      menstruation and will be continued according to their transfer type (blastocyst or cleavage).
      βhCG will be assessed 14 days after embryo transfer. Treatment cycle outcomes will be
      compared between 2 groups.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>November 2015</start_date>
  <completion_date type="Anticipated">December 2017</completion_date>
  <primary_completion_date type="Anticipated">November 2017</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Pregnancy Rate</measure>
    <time_frame>4weeks</time_frame>
    <description>Evaluation of pregnancy rate in women 4 weeks after embryos transfer (ET).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Miscarriage Rate</measure>
    <time_frame>14 days</time_frame>
    <description>Evaluation the miscarriage rate in women 14 days after embryo transfer (ET) with BHCG titration.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Implantation Rate</measure>
    <time_frame>14 days</time_frame>
    <description>Evaluation the implantation rate in women 14 days after embryo transfer (ET) with BHCG titration..</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Ongoing pregnancy rate</measure>
    <time_frame>14 days</time_frame>
    <description>Evaluation the ongoing pregnancy rate in women 14 days after embryo transfer (ET) with BHCG titration..</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">220</enrollment>
  <condition>Infertility</condition>
  <arm_group>
    <arm_group_label>Blastocyst transplantation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The infertile women who underwent intra- uterus transferring of blastocyst from thawed cleavage embryo</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>The infertile women who underwent intra- uterus transferring of thawed cleavage embryo.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Blastocyte Transferring</intervention_name>
    <description>Intra-uterine transferring of blastocyst from thawed cleavage embryo in infertile women.</description>
    <arm_group_label>Blastocyst transplantation</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Embryo Transferring</intervention_name>
    <description>Inta-uterine transferring of thawed cleavage embryo transfer in infertile women.</description>
    <arm_group_label>Control</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  The patients with first type of infertility

          -  Age ≤ 37 years

          -  Long ovulation induction protocol

        Exclusion Criteria:

          -  Any previous surgery on the uterus and ovaries

          -  Uterine factor infertility

          -  Sever Male factor infertility (TESE, TESA ،Oligoteratozoospermia)

          -  Recurrent abortion

          -  The women with poor ovarian reserve
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>16 Years</minimum_age>
    <maximum_age>37 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Hamid Gourabi, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Head of Royan Institute</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Tahereh Madani, MD</last_name>
    <role>Study Director</role>
    <affiliation>Department of Endocrinology and Female Infertility, Reproductive Biomedicine Research Center, Royan Institute for Reproductive Biomedicine, ACECR, Tehran, Iran</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Poopak Eftekhari-Yazdi, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Endocrinology and Female Infertility, Reproductive Biomedicine Research Center, Royan Institute for Reproductive Biomedicine, ACECR, Tehran, Iran</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Nadia Jahangiri, MSc</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Endocrinology and Female Infertility, Reproductive Biomedicine Research Center, Royan Institute for Reproductive Biomedicine, ACECR, Tehran, Iran</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Nasser Aghdami, MD,PhD</last_name>
    <phone>(+98)2123562000</phone>
    <phone_ext>516</phone_ext>
    <email>nasser.aghdami@royaninstitute.org</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Leila Arab, MD</last_name>
    <phone>(+98)2123562000</phone>
    <phone_ext>414</phone_ext>
    <email>Leara91@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Royan Institute</name>
      <address>
        <city>Tehran</city>
        <country>Iran, Islamic Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nasser Aghdami, MD,PhD</last_name>
      <phone>(+98)2123562000</phone>
      <phone_ext>516</phone_ext>
      <email>nasser.aghdami@royaninstitute.org</email>
    </contact>
    <contact_backup>
      <last_name>Leila Arab, MD</last_name>
      <phone>(+98)2123562000</phone>
      <phone_ext>414</phone_ext>
      <email>Leara91@gmail.com</email>
    </contact_backup>
    <investigator>
      <last_name>Fatemeh Hassani, MSc</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Akram Vahedi, BSc</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Saeid Hesam, MSc</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Iran, Islamic Republic of</country>
  </location_countries>
  <link>
    <url>http://Royaninstitute.org</url>
  </link>
  <verification_date>February 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 2, 2016</study_first_submitted>
  <study_first_submitted_qc>February 9, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 12, 2016</study_first_posted>
  <last_update_submitted>February 9, 2016</last_update_submitted>
  <last_update_submitted_qc>February 9, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 12, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Cleavage stage blastocyst transfer cryopreservation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infertility</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

